Combined Medical-Surgical Grand Round - Michaelmas term
Professors David Cranston, Robin Cleveland and Constantin Coussios
Clinical Research Surgical Grand Rounds
Thursday, 12 December 2019, 1pm to 2pm
Lecture Theatre 1, Academic Centre, John Radcliffe Hospital, Oxford
"The power of sound"
Biographies
Robin Cleveland is a Professor of Engineering Science at the University of Oxford and his research is based at the Biomedical Ultrasound, Biotherapy and Biopharmaceuticals Laboratory (BUBBL) at the Institute of Biomedical Engineering. Active areas of research include: therapeutic use of ultrasound for ablation and drug delivery, ultrasound neuro-modulation, the mechanisms of traumatic brain injury, and the use of shock waves to break kidney stones. He is a Fellow of the Acoustical Society of America and a past Associate Editor of the Journal. He has been on the board of the International Society of Therapeutic Ultrasound and was the Scientific Chair of the 2019 International Symposium on Therapeutic Ultrasound. He is the Chair of the next International Symposium on Nonlinear Acoustics to be held in Oxford in 2021.
Title of talk: "Focused ultrasound neuromodulation of visual pathways in humans"
David Cranston is Associate Professor of Surgery in the Nuffield Department of Surgical Sciences in the University of Oxford and honorary Consultant Urological Surgeon in Oxford University Hospitals Foundation Trust. He qualified from Bristol University in 1975 and was awarded his DPhil in Oxford in 1986 for kidney transplantation based research. Since 2001, he has been Clinical Director of the High Intensity Focused Ultrasound Unit in Oxford with a big research link with The National Ultrasound Engineering Research Centre in Chongqing China.
Constantin Coussios is the Professor of Biomedical Engineering (Drug Delivery) and heads the Biomedical Ultrasonics, Biotherapy & Biopharmaceuticals Laboratory (BUBBL) in the Oxford Institute of Biomedical Engineering . He is also the Director of the Oxford Centre for Drug Delivery Devices (OxCD3), supported by an EPSRC Programme grant. He holds a B.A., M.Eng., M.A. and Ph.D. from the University of Cambridge.
Chair: Professor Richard J Cornall
All members of the University and NHS clinical staff are welcome.